WALTHAM, Mass., April 2, 2015 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food ...

Alere Inc ALR recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test, a unified solution of rapid and accurate diagnosis of RSV diseases. Notably, ...

(Reuters) - Alere Inc said it initiated a voluntary recall of certain blood clot test strips in the United States following reports of nine serious adverse events that included bleeding related to the ...

BOSTON (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last ...

Massachusetts-based medical device manufacturer Alere and its San Diego subsidiary will pay $33.2 million to resolve allegations they violated the False Claims Act. The Department of Justice said ...

Pune, Maharashtra, India, January 19 2021 (Wiredrelease) MarketResearch.Biz –:An extensive and elaborate primary research on Global Drug Screening Market report sheds light on numerous facets such as ...